Betamicin
- Level
- Commodity
- Parent
- 51281600
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51281606This classification denotes an aminoglycoside antibiotic with the molecular formula C19H38N4O10, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 67W9DGG4C7 chemically known as d-streptamine, o-6-amino-6-deoxy-.alpha.-d-glucopyranosyl-(1->4)-o-(3-deoxy-4-c-methyl-3-(methylamino)-.beta.-l-arabinopyranosyl-(1->6))-2-deoxy- but generally known as betamicin, which bears US NIH Compound Identifier 37569. European Medicines Agency schedules Betamicin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05799MIG. The term BETAMICIN is an International Non-Proprietary Name or INN. Most nations schedule betamicin under HS 29419000 and SITC 54139. As of Q4 2014, BETAMICIN remains the US FDA Preferred Term for this commodity. Betamicin bears US NLM identifiers UMLS ID C0061208 and NCI Concept Code C81375. SMILES: O(C1C(O)C(OC2OC(C(O)C(O)C2O)CN)C(N)CC1N)C1OCC(O)(C(NC)C1O)C.
Same parent
Under 51281600 · 75Activities that produce or sell this
KBLI · 9Inherited from family 51280000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.